Based on mRNA expression results, tPA antagonist tPA-stop and MMP-9 antagonist JAJN966, were applied to determine whether JWKXS improved cognitive deficits by regulating neurotrophic factor transformation via tPA and MMP-9. This evidence concerns the gene MMP9 and Cognitive impairment.